CardioBrief: After Yet Another Failure, Stem Cell Leaders Double Down – MedPage Today
|
CardioBrief: After Yet Another Failure, Stem Cell Leaders Double Down
MedPage Today Despite an unrelieved history of negative trials, stem cell leaders continue to defend their field. In response to the failure of yet another cardiac stem clinical trial, Roberto Bolli, a prominent leader in the field, argued that it's time for a … Stem Cell Company Combining Stem Cell Therapy with Hyperbaric Oxygen Treatment Find Out How the Global Stem Cell Banking Market Is Growing At A CAGR of XX.X% from 2016 to 2021 R3 Stem Cell Now Offering Regenerative Medicine Treatment in Oklahoma City |
